Key facts
- It has raised $50K; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include Right Side Capital Management, MARL Accelerator, SKEMA Entrepreneurs.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for GynEcho
- ·The full record, as it builds
Funding rounds
No funding rounds for GynEcho are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GynEcho
Developer of AI-powered diagnostic platforms designed to assist in conducting fetal ultrasound examinations. The company's platform automates fetal biometry measurements, provides intelligent anatomical plane selection, and offers real-time expert-level analysis through AI agents and automated reporting, enabling healthcare providers to perform accurate and efficient ultrasound exams with minimal training, increasing accessibility in remote areas, and reducing the need for expensive equipment.
- Sector
- Healthcare
- HQ
- Wilmington, DE, United States
- Founded
- 2023
- Website
- gynecho.ai/
- Ownership
- Privately Held (backing)
GynEcho doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GynEcho shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GynEcho in its N-PORT filings yet. We sweep new filings monthly.